HomePIDILITIND › Filing
🔔 Get instant alerts when PIDILITIND files quarterly results on BSE Start free trial →

Press Release

Filed: 04 Aug 2026, 14:36 IST Exchange: BSE Category: Financial Results — Press Release
Press Release - Q1FY27 - Consolidated revenue grew 21.3% to Rs 4,541 Cr; PAT up 30.3% to Rs 884 Cr - Standalone net sales rose 22.2% with underlying volume growth (UVG) of 11.3% - Consumer & Bazaar segment revenue up 22.5% with UVG 12.2%; B2B revenue up 16.0% with UVG 7.3% - Gross margin contracted ~70-90 bps due to West Asia inflation impact - EBITDA margin improved ~80-120 bps to 26.3-26.4% on both standalone and consolidated basis - Domestic demand remains resilient with strong urban and rurban market performance - Company managing raw material inflation and supply chain risks with disciplined cost control
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 PIDILITIND — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add PIDILITIND to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Pidilite Industries Limited

Important. The summary above is generated automatically from Pidilite Industries Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.